BioSpace News Archive

ESSA Pharma Inc. announced that each of its President and CEO, David R Parkinson and its Executive VP & COO, Peter Virsik, have established ASDPs in accordance with applicable US and Canadian securities legislation, including U.S. SEC Rule 10b5-1 and the recommended practices set forth in the Canadian Securities Administrators’ Staff Notice 55-317 and the Company’s internal policies.

Exacta Bioscience and Ginkgo Bioworks announced that Exacta is leveraging Ginkgo’s end-to-end agricultural R&D services to run a fermentation optimization and scale-up program to enhance one of its crop protection products, FitoRoot®, paving the way for large-scale commercialization.

BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced that the Company will participate in the Morgan Stanley 21st Annual Global Healthcare Conference on Monday, September 11th, 2023 with a fireside chat at 9:20 am ET.

Precision BioSciences, Inc., a gene editing company developing ARCUS®-based in vivo gene editing therapies, announced that it will host its in vivo gene editing R&D Day on Tuesday, September 12, 2023 from 9:00-11:30 AM ET.

Septerna announced the addition of David Martin, Ph.D., as Senior Vice President of Development Sciences, and Samira Shaikhly as Chief People Officer to its leadership team.

StatLab Medical Products, a developer and manufacturer of diagnostic supplies and equipment, is pleased to announce that its Board of Directors has appointed Sung-Dae Hong as Chief Executive Officer and Board Member, effective August 28, 2023.

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncology, inflammatory and liver diseases, announced financial results for the six months ended June 30, 2023.

Exscientia plc announced that members of Exscientia management will participate in the following upcoming investor conferences in September: 2023 Wells Fargo Healthcare Conference.

Enanta Pharmaceuticals, Inc. announced that members of management will participate in four investor conferences being webcast in September and provide a business update: Wells Fargo Securities Healthcare Conference: Fireside Chat at 2:15 p.m. ET on September 7, 2023 H.C.

CareDx, Inc. announced that the Company will participate in the H.C. Wainwright 25th Annual Global Investment Conference.